NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jianshun Biosciences Co., Ltd.

Jianshun Biosciences Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://jianshunbio.com/

Last Round

Series D

Dec 27, 2021

Est. Valuation

$1.34B

Total Funding Raised

$420.85M

Company Overview

Jianshun Biosciences Co., Ltd. is a biotechnology company that specializes in the development, production, and sale of serum-free cell culture media for the biopharmaceutical, vaccine, and cellular agriculture industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

cell culture mediabioprocessing reagentschemically defined mediaADCF mediaanimal-derived component-freebioprocessingcell culture supplementsbiopharma manufacturingCDMO servicescustom media developmentserum-free mediabiotech supply chaincultivated meat medialab reagentsbioprocess consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jianshun Biosciences Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Jianshun Biosciences Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Jianshun Biosciences Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DDec 27, 2021
Series CMar 10, 2021
Series BJul 24, 2020
Series AJan 3, 2019

Jianshun Biosciences Co., Ltd. Investors

Notable investors and investment history

Jianshun Biosciences Co., Ltd. investors
InvestorRounds
New Alliance CapitalSeries A
中信金石投资有限公司Series C, Series D, Series B
CCB InternationalSeries B
Fosun InternationalSeries C
CICC CapitalSeries C
Addor CapitalSeries A
China Reform Holdings CorporationSeries C

Jianshun Biosciences Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jianshun Biosciences Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jianshun Biosciences Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range10
Year Founded2011
Last FundingDec 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.